Radiopharm Theranostics Limited

RADX · NASDAQ
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Assets
Cash & Equivalents$29,117$18,575$11,699$26,979
Short-Term Investments$0$0$0$0
Receivables$10,400$987$4,468$56
Inventory$0$0$0$0
Other Curr. Assets$337$3,286$133$229
Total Curr. Assets$39,854$22,848$16,300$27,264
Property Plant & Equip (Net)$53$61$68$2
Goodwill$0$0$0$0
Intangibles$46,574$49,087$58,541$56,075
Long-Term Investments$0$40$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$40$40
Total NC Assets$46,628$49,188$58,650$56,117
Other Assets$0$0$0$0
Total Assets$86,482$72,036$74,950$83,381
Liabilities
Payables$6,347$6,435$2,957$1,190
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$1,721$0$0$0
Other Curr. Liab.$6,865$11,141$10,273$6,689
Total Curr. Liab.$14,933$17,576$13,229$7,879
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$28,677$27,107$16,141$12,540
Total NC Liab.$28,677$27,107$16,141$12,540
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$43,610$44,683$29,370$20,419
Equity
Pref Stock$0$0$0$0
Common Stock$176,558$100,682$97,230$86,759
Retained Earnings-$145,733-$111,339-$65,354-$30,824
AOCI$13,117$37,930$10,361$7,028
Other Equity$850$850$2,147$0
Total Equity$44,792$28,123$44,384$62,963
Supplemental Information
Minority Interest-$1,920-$769$1,195$0
Total Liab. & Tot. Equity$86,482$72,036$74,950$83,381
Net Debt-$29,117-$18,575-$11,699-$26,979